Comparative toxicity of 226Ra, 239Pu, 241Am, 249Cf, and 252Cf in C57BL/Do black and albino mice.
Groups of C57BL/Do (black and albino) mice were injected with graded activities of 226Ra, 239Pu, 241Am, 249Cf, or 252Cf and were followed throughout life. Bone sarcoma was the principal radiation-induced end point, and the risks associated with average skeletal doses of the four transuranium radionuclides, relative to radium, were determined. The relative biological effectiveness (RBE) was calculated for each emitter by dividing its risk coefficient (bone sarcomas per 10(6) mouse-rad) by the risk coefficient for 226Ra. Combined data for males and females in both black and albino mice gave the following values +/- SD for the RBE relative to 226Ra = 1.0: 239Pu = 15.3 +/- 3.9, 241Am = 4.9 +/- 1.4, 249Cf = 5.0 +/- 1.4, and 252Cf = 2.6 +/- 0.8. About 70% of the tumors occurred in the axial skeleton, and the risk coefficient for females averaged about four times higher than for males when all five nuclides were included. The RBE of fission fragment irradiation from 252Cf for cancer induction, relative to alpha irradiation, for the combined data in all of the animals given 252Cf and 249Cf, was 0.02 +/- 0.28, in agreement with the calculated theoretical value of 0.03, based on the ratio of summed track lengths in tissue.
D000512:Alpha Particles; D000576:Americium / Q000633:toxicity*; D000818:Animals; D001859:Bone Neoplasms / Q000209:etiology; D002142:Californium / Q000633:toxicity*; D004307:Dose-Response Relationship, Radiation; D005260:Female; D007275:Injections, Intravenous; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008954:Models, Biological; D009381:Neoplasms, Radiation-Induced / Q000209:etiology; D011005:Plutonium / Q000633:toxicity*; D011851:Radioactivity; D011883:Radium / Q000633:toxicity*; D012306:Risk; D012513:Sarcoma, Experimental / Q000209:etiology; D012737:Sex Factors
D011005:Plutonium; D002142:Californium; D000576:Americium; D011883:Radium